In human cardiovascular diseases (CVD) and inflammatory conditions, the inflammatory intermediate CD14+CD16+ monocyte is increased, and they have been shown to interact with T cells, influencing immune activation and antigen presentation [41]. This evidence concerns the gene CD14 and cardiovascular disorder.